Resource: Therapeutic Education Programs (Cancer Institute Strasbourg Europe): Difference between revisions
No edit summary |
m (Update categories.) |
||
| (3 intermediate revisions by the same user not shown) | |||
| Line 91: | Line 91: | ||
<span style="display:none">Spleen</span> | <span style="display:none">Spleen</span> | ||
<span style="display:none">Leukemia</span> | <span style="display:none">Leukemia</span> | ||
<span style="display:none">isPatientResource</span> | |||
<span style="display:none">hasCancerType::C00-D48: All neoplasms</span> | <span style="display:none">hasCancerType::C00-D48: All neoplasms</span> | ||
<span style="display:none">hasCancerType::C00-C97: All cancer types</span> | |||
<span style="display:none">hasCancerType::C00-C14: Mouth/throat cancers</span> | |||
<span style="display:none">hasCancerType::C15-C26: Digestive system cancers</span> | |||
<span style="display:none">hasCancerType::C30-C39: Lung/chest cancers</span> | |||
<span style="display:none">hasCancerType::C40-C41: Bone cancers</span> | |||
<span style="display:none">hasCancerType::C43-C44: Skin cancers/melanoma</span> | |||
<span style="display:none">hasCancerType::C45-C49: Soft tissue cancer</span> | |||
<span style="display:none">hasCancerType::C50: Breast cancer</span> | |||
<span style="display:none">hasCancerType::C51-C58: Female genitalia cancers</span> | |||
<span style="display:none">hasCancerType::C60-C63: Male genitalia cancer</span> | |||
<span style="display:none">hasCancerType::C64-C68: Urinary system cancers</span> | |||
<span style="display:none">hasCancerType::C69-C72: Eye and brain cancer</span> | |||
<span style="display:none">hasCancerType::C73-C75: Thyroid and other gland cancers</span> | |||
<span style="display:none">hasCancerType::C76-C80: Cancers of unknown or unspecified areas</span> | |||
<span style="display:none">hasCancerType::C81-C96: Cancers of the blood and immune system</span> | |||
<span style="display:none">hasCancerType::C97-C97: Cancers in multiple locations from the start</span> | |||
<span style="display:none">hasCancerType::D00-D09: Early-stage cancers not yet spread</span> | |||
<span style="display:none">hasCancerType::D10-D36: Benign tumour</span> | |||
<span style="display:none">hasCancerType::D37-D48: Growths of uncertain nature</span> | |||
<span style="display:none">hasCancerType::unknown</span> | |||
<span style="display:none">Head</span> | |||
<span style="display:none">Neck</span> | |||
<span style="display:none">Oral</span> | |||
<span style="display:none">Oral cavity</span> | |||
<span style="display:none">Pharynx</span> | |||
<span style="display:none">Pharyngeal</span> | |||
<span style="display:none">Tongue</span> | |||
<span style="display:none">Lingual</span> | |||
<span style="display:none">Nasal cavity</span> | |||
<span style="display:none">Nasal</span> | |||
<span style="display:none">Sinonasal</span> | |||
<span style="display:none">Sinus</span> | |||
<span style="display:none">Sinuses</span> | |||
<span style="display:none">Paranasal sinuses</span> | |||
<span style="display:none">Ear</span> | |||
<span style="display:none">Mandible</span> | |||
<span style="display:none">Maxilla</span> | |||
<span style="display:none">Jaw</span> | |||
<span style="display:none">Esophageal</span> | |||
<span style="display:none">Gastric</span> | |||
<span style="display:none">Intestinal</span> | |||
<span style="display:none">Bowel</span> | |||
<span style="display:none">Colorectal</span> | |||
<span style="display:none">Appendix</span> | |||
<span style="display:none">Appendiceal</span> | |||
<span style="display:none">Duodenum</span> | |||
<span style="display:none">Jejunum</span> | |||
<span style="display:none">Ileum</span> | |||
<span style="display:none">Anal</span> | |||
<span style="display:none">Perianal</span> | |||
<span style="display:none">Hepatic</span> | |||
<span style="display:none">Biliary</span> | |||
<span style="display:none">Hepatobiliary</span> | |||
<span style="display:none">Pulmonary</span> | |||
<span style="display:none">Thorax</span> | |||
<span style="display:none">Thoracic</span> | |||
<span style="display:none">Chest</span> | |||
<span style="display:none">Mediastinal</span> | |||
<span style="display:none">Pleural</span> | |||
<span style="display:none">Cutaneous</span> | |||
<span style="display:none">Dermal</span> | |||
<span style="display:none">Epidermal</span> | |||
<span style="display:none">Subcutaneous</span> | |||
<span style="display:none">Skeletal</span> | |||
<span style="display:none">Osseous</span> | |||
<span style="display:none">Chondral</span> | |||
<span style="display:none">Extremity</span> | |||
<span style="display:none">Axilla</span> | |||
<span style="display:none">Axillary</span> | |||
<span style="display:none">Mammary</span> | |||
<span style="display:none">Cervical</span> | |||
<span style="display:none">Uterine</span> | |||
<span style="display:none">Endometrial</span> | |||
<span style="display:none">Ovarian</span> | |||
<span style="display:none">Tubal</span> | |||
<span style="display:none">Fallopian</span> | |||
<span style="display:none">Vaginal</span> | |||
<span style="display:none">Vulvar</span> | |||
<span style="display:none">Adnexal</span> | |||
<span style="display:none">Renal</span> | |||
<span style="display:none">Urothelial</span> | |||
<span style="display:none">Ureteral</span> | |||
<span style="display:none">Urethral</span> | |||
<span style="display:none">Prostatic</span> | |||
<span style="display:none">Testicular</span> | |||
<span style="display:none">Penile</span> | |||
<span style="display:none">Ocular</span> | |||
<span style="display:none">Orbital</span> | |||
<span style="display:none">Retinal</span> | |||
<span style="display:none">Optic nerve</span> | |||
<span style="display:none">Meninges</span> | |||
<span style="display:none">Meningeal</span> | |||
<span style="display:none">Cerebral</span> | |||
<span style="display:none">Cerebellar</span> | |||
<span style="display:none">Brainstem</span> | |||
<span style="display:none">Lymphatic</span> | |||
<span style="display:none">Lymphoid</span> | |||
<span style="display:none">Lymphoma</span> | |||
<span style="display:none">Hematologic</span> | |||
<span style="display:none">Hematopoietic</span> | |||
<span style="display:none">Myeloma</span> | |||
<span style="display:none">Plasma cell</span> | |||
<span style="display:none">Diaphragm</span> | |||
<span style="display:none">Peripheral nerve</span> | |||
<span style="display:none">Heart</span> | |||
<span style="display:none">Cardiac</span> | |||
<span style="display:none">Endocrine</span> | |||
Latest revision as of 12:14, 14 December 2025
Go back to Cancer Institute Strasbourg Europe page
Primary purpose: It offers group workshops and individual consultations with various healthcare experts, all aimed at empowering patients to take control of their treatment, address potential side effects, and foster better adherence to their prescribed therapies. It also addresses treated patients to help them return to their daily lives. There are two types of programs available: "Après cancer du sein", aimed at people who finished breast cancer treatment, and "Thérapie orale", aimed at patients under oral anti-cancer drugs.
Cancer areas of interest: C00-D48: All neoplasms. Click here to learn more.
Access to information: Click here to access. The programs "Après cancer du sein" and "Thérapie orale" are presented on page 58 of the report or page 30 of the pdf.